Nomura Holdings Inc Madrigal Pharmaceuticals, Inc. Transaction History
Nomura Holdings Inc
- $70.8 Billion
- Q4 2024
A detailed history of Nomura Holdings Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 8,800 shares of MDGL stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,800
Previous 1,394
531.28%
Holding current value
$2.99 Million
Previous $295,000
820.34%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MDGL
# of Institutions
334Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$751 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$694 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$690 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$678 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$671 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.81B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...